IP Library Granted Patent US 9,133,394
Granted Patent B2
US 9,133,394 · App. 14/208,079 · Granted Sep 15, 2015

Polyhedral oligomeric silsesquioxane nanocrystal stabilization ligands

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,133,394
App. No.
14/208,079
Granted
Sep 15, 2015
Kind
B2
Abstract

Quantum-dot binding ligands with silsesquioxane moieties are provided. The quantum-dot binding ligands include a multiplicity of amine or carboxy binding ligands in combination with silsesquioxane moieties providing improved stability for the ligated quantum dots. The ligands and coated nanostructures of the present invention are useful for close packed nanostructure compositions, which can have improved quantum confinement and/or reduced cross-talk between nanostructures.

Claims (38)

1. A quantum dot binding-ligand having a structure according to Formula I

wherein:

A is a polyhedral oligomeric silsesquioxane (POSS) moiety comprising 6 to 12 silicon atoms;

each group —O—Si(R 1 ) 2 -L-(R 2 ) q is bound to a silicon atom in the POSS moiety;

each R 1 is independently selected from the group consisting of H and C 1-6 alkyl;

each L is independently selected from the group consisting of C 3-8 alkylene, C 3-8 heteroalkylene, and C 3-8 alkylene-(C(O)NH—C 2-8 alkylene) q ;

each R 2 is independently selected from the group consisting of C(O)OH and NR 2a R 2b , wherein R 2a and R 2b are each independently selected from the group consisting of H and C 1-6 alkyl;

each R 3 is independently selected from the group consisting of C 8-20 alkyl, C 8-20 heteroalkyl, C 8-20 alkenyl, C 8-20 alkynyl, cycloalkyl, and aryl;

the subscript m is an integer from 1 to 20;

the subscript n is an integer from 1 to 20; and

each subscript q is independently an integer from 2 to 10.

2. The quantum dot binding-ligand according to claim 1 , wherein each R 1 is independently C 1-3 alkyl.

3. The quantum dot binding-ligand according to claim 1 , wherein each R 1 is methyl.

4. The quantum dot binding-ligand according to claim 1 , wherein each -L-(R 2 ) q group is independently selected from the group consisting of C 3-8 alkylene-(R 2 ) 2 , and C 3-8 alkylene-(C(O)NH—C 2-8 alkylene-(R 2 ) 2 .

5. The quantum dot binding-ligand according to claim 1 , wherein each -L-(R 2 ) q group is independently selected from the group consisting of:

6. The quantum dot binding-ligand according to claim 1 , wherein each R 2 is C(O)OH.

7. The quantum dot binding-ligand according to claim 6 , wherein each L is C 3-8 alkylene.

8. The quantum dot binding-ligand according to claim 6 , wherein each -L-(R 2 ) q group is:

9. The quantum dot binding-ligand according to claim 1 , wherein each R 2 is NH 2 .

10. The quantum dot binding-ligand according to claim 9 , wherein each L is independently C 3-8 alkylene-(C(O)NH—C 2-8 alkylene) q ; and

each subscript q is 2.

11. The quantum dot binding-ligand according to claim 10 , wherein each -L-(R 2 ) q group is:

12. The quantum dot binding-ligand according to claim 1 , wherein each R 3 is independently selected from the group consisting of octyl, isooctyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, icosyl, cyclopentyl, cyclohexyl, cyclooctyl, norbornyl, adamantyl, phenyl, naphthyl, and anthracenyl.

13. The quantum dot binding-ligand according to claim 1 , wherein R 3 is selected from the group consisting of cyclohexyl, phenyl, and isooctyl.

14. The quantum dot binding-ligand according to claim 1 , wherein the subscript m is an integer from 5 to 10.

15. The quantum dot binding-ligand according to claim 1 , wherein the subscript m is 7.

16. The quantum dot binding-ligand according to claim 1 , wherein the subscript n is an integer from 1 to 6.

17. The quantum dot binding-ligand according to claim 1 , wherein the subscript n is 3.

18. The quantum dot binding-ligand according to claim 1 , wherein the POSS moiety has the following structure:

19. The quantum dot binding-ligand according to claim 18 , wherein:

each R 1 is methyl;

each -L-(R 2 ) q group is selected from the group consisting of:

each R 3 is selected from the group consisting of cyclohexyl, phenyl, and isooctyl;

the subscript m is 7; and

the subscript n is 3.

20. A composition comprising:

a quantum dot binding-ligand of claim 1 ; and

a first population of light emitting quantum dots (QDs).

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE ASSIGNEE TO BE: 2-1-1, NISHI-SHINJUKU SHINJUKU-KU TOKYO, JAPAN 163-0043 PREVIOUSLY RECORDED AT REEL: 065114 FRAME: 0769. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 9, 2023
From: NANOSYS, INC.
To: SHOEI CHEMICAL INC.
Reel/Frame 065271/0540 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2023
From: NANOSYS, INC.
To: SHOEI CHEMICAL INC.
Reel/Frame 065114/0769 →
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT RECORDED AT REEL 059569 / FRAME 0840 Recorded Sep 7, 2023
From: FORTRESS CREDIT CORP.,
To: NANOSYS, INC.
Reel/Frame 064836/0263 →
SECURITY INTEREST Recorded Apr 1, 2022
From: NANOSYS, INC.
To: FORTRESS CREDIT CORP., AS AGENT
Reel/Frame 059569/0840 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY COLLATERAL AT REEL/FRAME NO. 49170/0482 Recorded Jul 1, 2021
From: OCEAN II PLO, LLC, AS AGENT
To: NANOSYS, INC.
Reel/Frame 056752/0073 →
SECURITY INTEREST Recorded Jan 17, 2019
From: NANOSYS, INC.
To: OCEAN II PLO, LLC
Reel/Frame 049170/0482 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2014
From: FREEMAN, WILLIAM P; FURUTA, PAUL; DUBROW, ROBERT; PARCE, J. WALLACE
To: NANOSYS, INC.
Reel/Frame 032576/0658 →